Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Accumulated Expenses (2017 - 2025)

Catheter Precision (VTAK) has disclosed Accumulated Expenses for 9 consecutive years, with $95000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses rose 493.75% to $95000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $95000.0, a 493.75% increase, with the full-year FY2024 number at $1.4 million, up 3053.49% from a year prior.
  • Accumulated Expenses was $95000.0 for Q3 2025 at Catheter Precision, down from $1.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $7.5 million in Q4 2022 to a low of $4000.0 in Q2 2024.
  • A 5-year average of $1.4 million and a median of $457500.0 in 2021 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: plummeted 99.79% in 2024, then skyrocketed 33800.0% in 2025.
  • Catheter Precision's Accumulated Expenses stood at $4.1 million in 2021, then surged by 81.69% to $7.5 million in 2022, then crashed by 99.43% to $43000.0 in 2023, then surged by 3053.49% to $1.4 million in 2024, then plummeted by 92.99% to $95000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Accumulated Expenses are $95000.0 (Q3 2025), $1.4 million (Q2 2025), and $38000.0 (Q1 2025).